Concepedia

Author

Jörg Petersen

Universität Hamburg

Also Known As

Barbara Rehermann, Herbert Foltinek, Jorg Petersen, Jörg Petersen, Petersen, Jörg, Stephan Ludwig Roth

124

Publications

7.4K

Citations

41

H-Index

72

Concepts

All Affiliations

Universität HamburgAsklepios Klinik St. GeorgUniversity Medical Center Hamburg-EppendorfMedizinische Hochschule HannoverInstitute for Interdisciplinary Medicine
JP

About

Jörg Petersen is an author at Universität Hamburg specializing in medicine, hepatitis, and hepatology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

20

23

3K

2

Engineering

3

3

183

3

Health Sciences

3

3

204

4

Social Sciences

2

2

80

5

Natural Sciences

1

1

61

Jörg Petersen

×

47

Publications

5K

Citations

34

H-Index

YearCitations

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy1 ☆

Bettina Werle–Lapostolle, Scott Bowden, Stephen Locarnini,

Gastroenterology

2004

895

Long-Term Efficacy of Tenofovir Monotherapy for Hepatitis B Virus-Monoinfected Patients After Failure of Nucleoside/Nucleotide Analogues

Florian van Bömmel, Robert A. de Man, Heiner Wedemeyer,

Hepatology

2009

330

The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus

Tassilo Volz, Lena Allweiss, Mounira Ben ḾBarek,

Journal of Hepatology

2012

314

Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study

Thomas Berg, Karl‐Georg Simon, Stefan Mauss,

Journal of Hepatology

2017

309

Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients

W. Ray Kim, Thomas Berg, Tarik Asselah,

Journal of Hepatology

2015

284

Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians

P. Arends, Milan J. Sonneveld, Roeland Zoutendijk,

Gut

2014

205

Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort

Tania M. Welzel, Jörg Petersen, Kerstin Herzer,

Gut

2016

196

Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naïve patients with a partial virological response

Roeland Zoutendijk, Jurriën G.P. Reijnders, Ashley Brown,

Hepatology

2011

171

Ten‐year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection

Patrick Marcellin, David Wong, William Sievert,

Liver International

2019

151

Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals

Julia Dietz, S. Süsser, Johannes Vermehren,

Gastroenterology

2017

147

Page 1